Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
138,100
Employees138,100
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
138,100
Employees138,100

JNJ Key Statistics

Market cap
373.82B
Market cap373.82B
Price-Earnings ratio
17.35
Price-Earnings ratio17.35
Dividend yield
3.18%
Dividend yield3.18%
Average volume
7.26M
Average volume7.26M
High today
$156.95
High today$156.95
Low today
$154.73
Low today$154.73
Open price
$156.73
Open price$156.73
Volume
5.46M
Volume5.46M
52 Week high
$169.99
52 Week high$169.99
52 Week low
$140.68
52 Week low$140.68

JNJ News

Benzinga 13h
Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?

The U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical Industries Ltd. TEVA and Alvotech’s ALVO Selarsdi (ustekinumab-aekn) injection as i...

Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?
Simply Wall St 3d
Johnson & Johnson Is Increasing Its Dividend To $1.30

Johnson & Johnson ( ) will increase its dividend from last year's comparable payment on the 10th of June to $1.30. This takes the dividend yield to 3.4%, which...

Johnson & Johnson Is Increasing Its Dividend To $1.30
Benzinga 3d
Deal Dispatch: Chef Boyardee, Crumbl Appear Tasty To Buyers While Bankruptcies Tick Upward

New On The Block TSG Consumer Partners is reportedly eyeing a sweet deal—a minority stake in Crumbl, the Utah-based cookie empire that could be worth a jaw-dro...

Deal Dispatch: Chef Boyardee, Crumbl Appear Tasty To Buyers While Bankruptcies Tick Upward

Analyst ratings

52%

of 25 ratings
Buy
48%
Hold
52%
Sell
0%

More JNJ News

TipRanks 5d
Johnson & Johnson Shareholders Approve 2025 Director Nominees

An announcement from Johnson & Johnson ( (JNJ) ) is now available. D. Adamczyk announced his intention to retire from Johnson & Johnson‘s Board of Directors ef...

Simply Wall St 5d
Johnson & Johnson Gains FDA Approval For IMAAVY™ To Treat Myasthenia Gravis

recently experienced a 3% price increase in the last quarter, a period during which significant developments occurred for the company. Notably, the FDA granted...

Johnson & Johnson Gains FDA Approval For IMAAVY™ To Treat Myasthenia Gravis

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.